VORAXAZE

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United States

Active ingredients

The drug VORAXAZE contains one active pharmaceutical ingredient (API):

1 Glucarpidase UNII 2GFP9BJD79 - GLUCARPIDASE

Glucarpidase is a recombinant bacterial enzyme that hydrolyses the carboxyl-terminal glutamate residue from folic acid and structurally related molecules such asMTX. Glucarpidase converts MTX to its inactive metabolites DAMPA and glutamate. Read about Glucarpidase

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VORAXAZE Powder for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC
VORAXAZE Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AF09	Glucarpidase	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1614136, 1873672
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1211586001
Country: FR	Base de données publique des médicaments	Identifier(s): 60176597
Country: IT	Agenzia del Farmaco	Identifier(s): 049882018
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093991
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100467617
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69225001
Country: US	FDA, National Drug Code	Identifier(s): 50633-210